BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19520710)

  • 21. Precycle administration of GnRH antagonist and microdose HCG decreases clinical pregnancy rates without affecting embryo quality and blastulation.
    Bukulmez O; Rehman KS; Langley M; Carr BR; Nackley AC; Doody KM; Doody KJ
    Reprod Biomed Online; 2006 Oct; 13(4):465-75. PubMed ID: 17007662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    Fertil Steril; 1998 Dec; 70(6):1063-9. PubMed ID: 9848296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
    Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R
    Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells.
    Luo X; Xu J; Chegini N
    Reprod Biol Endocrinol; 2003 Dec; 1():125. PubMed ID: 14678567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HOXA10 protein expression in the endometrium of normally menstruating women after receiving GnRH antagonist.
    Sirayapiwat P; Triratanachat S; Tantbirojn P; Ruangvejvorachai P; Suwajanakorn S
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):321-5. PubMed ID: 23541416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Embryo implantation and GnRH antagonists: GnRH antagonists do not activate the GnRH receptor.
    Mannaerts B; Gordon K
    Hum Reprod; 2000 Sep; 15(9):1882-3. PubMed ID: 10966979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of gonadotrophin-releasing hormone agonists to trigger ovulation.
    Tay CC
    Hum Fertil (Camb); 2002 Feb; 5(1):G35-7; discussion G38-9, G41-8. PubMed ID: 11939159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.
    Al-Inany HG; Youssef MA; Aboulghar M; Broekmans F; Sterrenburg M; Smit J; Abou-Setta AM
    Cochrane Database Syst Rev; 2011 May; (5):CD001750. PubMed ID: 21563131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.
    Albano C; Felberbaum RE; Smitz J; Riethmüller-Winzen H; Engel J; Diedrich K; Devroey P
    Hum Reprod; 2000 Mar; 15(3):526-31. PubMed ID: 10686191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of the koala (Phascolarctos cinereus) anterior pituitary-gonadal axis with analogues of GnRH.
    Allen CD; Burridge M; Chafer ML; Nicolson VN; Jago SC; Booth RJ; Fraser G; Ensabella TJ; Zee YP; Lundie-Jenkins G; Holt WV; Lisle AT; Carrick FN; Curlewis JD; D'Occhio MJ; Johnston SD
    Reprod Fertil Dev; 2008; 20(5):598-605. PubMed ID: 18577357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation.
    Christin-Maitre S; Olivennes F; Dubourdieu S; Chabbert-Buffet N; Charbonnel B; Frydman R; Bouchard P
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):721-6. PubMed ID: 10848876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian stimulation for IVF and endometrial receptivity--the missing link.
    van der Gaast MH; Beckers NG; Beier-Hellwig K; Beier HM; Macklon NS; Fauser BC
    Reprod Biomed Online; 2002; 5 Suppl 1():36-43. PubMed ID: 12537780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
    Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
    Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGF-Enhanced GnRH-II Regulation in Decidual Stromal Cell Motility through Twist and N-Cadherin Signaling.
    Wu HM; Chen LH; Huang HY; Wang HS; Tsai CL
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exogenous progesterone for LH surge prevention is redundant in ovarian stimulation protocols.
    Messinis IE; Messini CI; Anifandis G; Daponte A
    Reprod Biomed Online; 2021 Apr; 42(4):694-697. PubMed ID: 33583700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.
    Tesarik J; Hazout A; Mendoza-Tesarik R; Mendoza N; Mendoza C
    Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Independent regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-3 in human endometrial stromal cells by gonadotropin-releasing hormone: implications in early human implantation.
    Raga F; Casañ EM; Wen Y; Huang HY; Bonilla-Musoles F; Polan ML
    J Clin Endocrinol Metab; 1999 Feb; 84(2):636-42. PubMed ID: 10022430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemistry, molecular biology and cell biology of gonadotropin-releasing hormone antagonists.
    Tan O; Bukulmez O
    Curr Opin Obstet Gynecol; 2011 Aug; 23(4):238-44. PubMed ID: 21666463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates.
    Acevedo B; Gomez-Palomares JL; Ricciarelli E; Hernández ER
    Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
    Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
    Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.